ASCT Versus Chemotherapy as First-Line Consolidation Therapy inT-Cell Lymphoma

Clinical trial NCT06149390 · COMPLETED

Trial details

NCT number: NCT06149390
Sponsor: Huazhong University of Science and Technology
Status: COMPLETED
Study type: OBSERVATIONAL

T-cell Lymphoma Adults

Start date: 2014-01-01
Primary completion: 2022-01-01
Enrollment: 347

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.